| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5514 | 2021 |
| Preexposure prophylaxis for HIV infection among African women L Van Damme, A Corneli, K Ahmed, K Agot, J Lombaard, S Kapiga, ... New England Journal of Medicine 367 (5), 411-422, 2012 | 1918 | 2012 |
| Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B. 1.351 variant SA Madhi, V Baillie, CL Cutland, M Voysey, AL Koen, L Fairlie, ... New England Journal of Medicine 384 (20), 1885-1898, 2021 | 1404 | 2021 |
| Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1380 | 2021 |
| Efficacy of NVX-CoV2373 Covid-19 vaccine against the B. 1.351 variant V Shinde, S Bhikha, Z Hoosain, M Archary, Q Bhorat, L Fairlie, U Lalloo, ... New England Journal of Medicine 384 (20), 1899-1909, 2021 | 695 | 2021 |
| Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial S Skoler-Karpoff, G Ramjee, K Ahmed, L Altini, MG Plagianos, ... The Lancet 372 (9654), 1977-1987, 2008 | 609 | 2008 |
| Respiratory syncytial virus vaccination during pregnancy and effects in infants SA Madhi, FP Polack, PA Piedra, FM Munoz, AA Trenholme, EAF Simões, ... New England Journal of Medicine 383 (5), 426-439, 2020 | 338 | 2020 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 254 | 2021 |
| HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised … K Ahmed, JM Baeten, M Beksinska, LG Bekker, EA Bukusi, D Donnell, ... The Lancet 394 (10195), 303-313, 2019 | 218 | 2019 |
| FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis AL Corneli, J Deese, M Wang, D Taylor, K Ahmed, K Agot, J Lombaard, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 66 (3), 324-331, 2014 | 212 | 2014 |
| Lessons learnt from implementing an empirically informed recruitment approach for FEM-PrEP, a large HIV prevention clinical trial C Parker, A Corneli, K Agot, J Odhiambo, J Asewe, K Ahmed, J Skhosana, ... Open Access Journal of Clinical Trials, 1-9, 2014 | 171 | 2014 |
| Participants' explanations for nonadherence in the FEM-PrEP clinical trial A Corneli, B Perry, K McKenna, K Agot, K Ahmed, J Taylor, F Malamatsho, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 71 (4), 452-461, 2016 | 138 | 2016 |
| Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries SR Knight, CA Shaw, R Pius, TM Drake, L Norman, AO Ademuyiwa, ... The Lancet 397 (10272), 387-397, 2021 | 136 | 2021 |
| Hormonal contraception and the risk of HIV acquisition among women in South Africa CS Morrison, S Skoler-Karpoff, C Kwok, PL Chen, J Van De Wijgert, ... Aids 26 (4), 497-504, 2012 | 114 | 2012 |
| Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B. 1.351 variant in South Africa SA Madhi, V Baillie, CL Cutland, M Voysey, AL Koen, L Fairlie, ... MedRxiv, 2021.02. 10.21251247, 2021 | 103 | 2021 |
| Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial S Delany-Moretlwe, C Lombard, D Baron, LG Bekker, B Nkala, K Ahmed, ... The Lancet infectious diseases 18 (11), 1241-1250, 2018 | 102 | 2018 |
| The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention A Van Der Straten, K Agot, K Ahmed, R Weinrib, EN Browne, K Manenzhe, ... Journal of the International AIDS Society 21 (3), e25094, 2018 | 97 | 2018 |
| Injectable progestin‐only contraception is associated with increased levels of pro‐inflammatory cytokines in the female genital tract J Deese, L Masson, W Miller, M Cohen, C Morrison, M Wang, K Ahmed, ... American journal of reproductive immunology 74 (4), 357-367, 2015 | 93 | 2015 |
| Facilitators of adherence to the study pill in the FEM-PrEP clinical trial A Corneli, B Perry, K Agot, K Ahmed, F Malamatsho, L Van Damme PloS one 10 (4), e0125458, 2015 | 87 | 2015 |
| Perception of HIV risk and adherence to a daily, investigational pill for HIV prevention in FEM-PrEP A Corneli, M Wang, K Agot, K Ahmed, J Lombaard, L Van Damme, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 67 (5), 555-563, 2014 | 87 | 2014 |
